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Abstract
Background: Varicella has an important impact on public health. Starting in 2004 in Taiwan, nationwide free
varicella vaccinations were given to 1-year-old children.
Methods: Our study investigated the epidemiological characteristics of varicella from 2000 to 2008, and assessed
the change of varicella epidemiology after the mass varicella immunization. ICD-9-CM codes related to varicella or
chickenpox (052, 052.1, 052.2, 052.7, 052.8, 052.9) were analyzed for all young people under 20 years of age
through the National Health Insurance database of Taiwan from 2000 to 2008.
Results: Case numbers of varicella or chickenpox significantly declined after the nationwide immunization in 2004.
Winter, particularly January, was the epidemic season of varicella. We found a significant post-vaccination decrease
in incidence among preschool children, especially 3 to 6 year-old children– the peak incidence was 66 per
thousand for 4 and 5 year-old children before the nationwide immunization (2000 to 2003), and the peak
incidence was 23 per thousand for 6 year-old children in 2008 (p < 0.001). Varicella-related hospitalization also
significantly decreased in children younger than 6 years after the nationwide immunization.
Conclusion: The varicella annual incidence and varicella-related hospitalization markedly declined in preschool
children after nationwide varicella immunization in 2004.
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Background
Varicella is the primary disease caused by the varicella-
zoster virus. It is a common and highly contagious dis-
ease and has a significant health impact on children.
Although the clinical course of varicella is usually mild
and self-limiting, varicella does cause complications and
mortality resulting in financial expense [1-3]. Chickenpox
or varicella now has been considered one of the most
common vaccine-preventable diseases in many countries
[4-7].
In Taiwan, some areas including Taipei City, Taichung
City and Taichung County gave the public free varicella
vaccinations for 1-2 year-old children before 2004. Taipei
City started the free varicella vaccination from 1998 and
Taichung City and Taichung County from 1999. Other
areas did not provide free varicella vaccination, but peo-
ple could receive varicella vaccination at their own
expense before 2004. Since 2004, free mass varicella
immunization has been given to all one year-old children
throughout Taiwan.
Since the implementation of National Health Insurance
(NHI) in 1995, there has been a healthcare database in
Taiwan. Taiwan has a population of 22.9 million people
and the land area of 36188 Km
2. Its population density is
633/Km
2.T a i w a n ’s NHI covered most of the health care
costs for 98% of its population in 2006 [8]; the remaining
2% of it population are living in the foreign countries or in
families with monthly household incomes less than 1000
US dollars. Taiwan’s NHI database includes health care
data collected from over 95% of the hospitals in Taiwan
for more than 96% of the population receiving health care.
We evaluated the disease burden and epidemiological
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any medium, provided the original work is properly cited.characteristics of varicella by using the NHI database to
find out the age-specific incidences, seasonal distribution
and varicella-related hospitalization from 2000 to 2008–
the period covering pre- and post-public free vaccination–
so we could compare the epidemiological characteristics
of varicella before and after the mass immunization.
Methods
Vaccination
The administration of a live attenuated varicella vaccine
was licensed in Taiwan in 1997. Both Merck and GlaxoS-
mithKline, pharmaceutical companies, provided the vari-
cella vaccines in Taiwan. In 2004 the varicella vaccine
was incorporated into Taiwan’s national immunization
program, and all 1-year-old children could receive the
varicella vaccine for free. The varicella coverage rate for
1-year-old children was 94% for the 2003 birth cohort,
95% for the 2004 cohort, and 97% for the 2005, 2006, and
2007 birth cohorts according to Taiwan’sN a t i o n a l
Immunization Information System which was developed
in the early 1990s [9]. When a child received a vaccine,
his or her vaccination would not only be recorded in a
child’s vaccination handbook but would also be reported
to the National Immunization Information System.
Data collection
Taiwan’s National Health Insurance (NHI) covered most
of the health care costs for 98% of its population. Tai-
wan’s NHI database includes health care data collected
from over 95% of the hospitals in Taiwan for more than
98% of the population receiving health care. From this
database, hospitalization and outpatient healthcare
records were collected from 2000 to 2008, and Interna-
tional Classifications of Diseases, Ninth Revision, Clinical
Modification (ICD-9-CM) codes related to varicella or
chickenpox were analyzed for all the population. The
age-specific annual incidence and hospitalization rate
were calculated. For calculating the annual population-
based incidence, the annual incidence was calculated by
dividing the number of varicella-related diseases by the
population, which was obtained from Department of Sta-
tistics, Ministry of the Interior, Taiwan from 2000 to
2008 [10].
Definitions
ICD-9-CM codes for chickenpox or varicella include the
following: 052 chickenpox; 052.0 post-varicella encephalitis,
post-chickenpox encephalitis; 052.1 varicella (hemorrhagic)
pneumonitis; 052.7 with other specified complications;
052.8 with unspecified complication; 052.9 varicella with-
out mention of complication.
For complications, we define varicella or chickenpox
patients to have complications in cases where the
patients had both ICD-9-CM codes for varicella or
chickenpox (052 and the other related codes) and also
ICD-9-CM codes for varicella-related complications
which include the following: central nervous system
including 320 meningitis, 322 cerebellitis, 323 encephali-
tis, 348 encephalopathy, 351 facial palsy, 331.81 Reye’s
syndrome, 780.3 febrile convulsion/seizure; skin and soft
tissue including 680-686 cellulites and abscess, 035 erysi-
pela, 728 pyomyositis and necrotizing fasciitis, 373 &
376.01 blepharitis, 034 & 041 scarlet fever and strepto-
coccal or staphylococcal infection; skeletal system includ-
ing 711 arthritis, 730-733 osteomyelitis; lower respiratory
tract infection including 480-487 pneumonia, 510-519
pneumonitis, 466 & 490 bronchitis; hematological sys-
tem- 287 thrombocytopenia, 283 & 285 anemia, 288 neu-
tropenia; 038 & 790 & 995.91-995.92 for sepsis and
bacteremia; 040-041 for other bacterial infection; 422
cardiomyopathy, 425 myocarditis; 070.5 & 070.9 & 573
for hepatitis.
Statistics
In univariate analysis, categorical variables were com-
pared with chi-square or Fisher’s exact test; continuous
variables were analyzed with Student’s t test. The differ-
ence of annual incidence among various age groups, the
difference of annual incidences in different years, and
the difference in seasonal distribution were measured
with appropriate c
2 test. A p value of < 0.05 was consid-
ered to be statistically significant. All statistical analyses
were performed with SAS software, version 9.0.
Results
Number of cases before and after the mass immunization
The monthly distribution of case numbers from 2000 to
2008 is demonstrated in Figure 1. Case numbers mark-
edly declined after the mass immunization in 2004, the
highest monthly number was 23460 in January 2000,
and the lowest was 2016 in September 2008. The peak
of varicella usually occurred during winter, especially in
January.
Age distribution
Overall age-specific case numbers and the cumulative
percentage of varicella in children from 2000 to 2008 are
shown in Figure 2, those of 2000 in Figure 3, and those
of 2008 in Figure 4. Children younger than 10 years old
represented 89% of all the cases and the peak age was 3
to 6 years from 2000 to 2008 (Figure 2). However, the
age distribution changed significantly after the mass
immunization (p < 0.001): 73% of varicella cases were
children less than 6 years of age in 2000 (before the mass
immunization, Figure 3) but only 24% of the cases were
children younger than 6 years of age in 2008 (4 years
after the mass immunization, Figure 4). In comparison
with age-specific case numbers of 2000 (Figure 3), those
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Page 2 of 7of 2008 were significantly lower (Figure 4) (p < 0.01). In
2008, school children had more varicella cases than the
kindergarteners.
Age-specific annual incidence
Figure 5 demonstrates the age-specific annual incidence of
varicella before and after the nationwide immunization. In
2000 to 2003 (before the nationwide immunization), the
peak incidence was in 4 and 5-year-old children with
annual incidence of 66 per thousand while in 2008, the
peak incidence occurred in 6-year-old children with
annual incidence of 23 per thousand (p < 0.01). After the
nationwide immunization in 2004, the annual incidence
significantly decreased among children younger than 7
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Figure 1 Monthly distribution of varicella case number from 2000 to 2008.
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Figure 2 Age-specific case number and cumulative percentage of varicella in children from 2000 to 2008.
Chang et al. BMC Infectious Diseases 2011, 11:352
http://www.biomedcentral.com/1471-2334/11/352
Page 3 of 70
5000
10000
15000
20000
25000
30000
  0   1   2   3   4   5   6   7   8   9  10 11  12 13 14 15 16  17 18 19
Age
C
a
s
e
 
n
u
m
b
e
r
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
C
u
m
u
l
a
t
i
v
e
 
p
e
r
c
e
n
a
t
g
e
Case number
Cumulative percentage
Figure 3 Age-specific case number and cumulative percentage of varicella in children in 2000, before the nationwide immunization.
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Figure 4 Age-specific case number and cumulative percentage of varicella in children in 2008, 4 years after the nationwide
immunization.
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Page 4 of 7years of age. In 2008, the annual incidence (6.8 per thou-
sand) of infants who could not receive the varicella vaccine
was even higher than that (3.2 to 5.9 per thousand) of 1 to
4-year-old children. Children beyond 7 years had similar
annual incidence before and after the mass immunization.
Age-specific varicella-related hospitalization incidence
The proportion of the number of varicella-related hospi-
talization to the number of overall varicella cases was
the highest in infants and declined with age in children.
Figure 6 shows that the annual incidence of varicella-
related hospitalization was the highest in infants. In
comparison with the annual incidence of 2000 to 2003
(before the nationwide immunization), the annual inci-
dence of hospitalization significantly declined in children
younger than 6 years of age from 2004 to 2008 (p <
0.01). From 2000 to 2008, the annual incidence of pre-
school children decreased obviously with the year.
Complications
Among the 21829 hospitalized cases, 561 (2.57%) had
central nervous system complications, 2721 (12.47%)
had skin or soft tissue infections, 4740 (21.71%) had
lower respiratory tract infections, 493 (2.26%) had hema-
tological complications, 281 (1.29%) had septicemia or
bacteremia, and 721 (3.30%) had hepatitis.
Twelve children died and Table 1 lists the demogra-
phy and complications of the 12 fatal varicella cases.
Five of them had underlying diseases including 2 with
acute lymphoblastic leukemia, 1 with severe combined
immunodeficiency, 1 with enzymopathy, and 1 with pul-
monary vascular anomaly. Most of them had complica-
tions of septicemia, skin or soft tissue infections, or
encephalitis, and 1 had Reye syndrome.
Discussion
Nationwide varicella immunization has resulted in a
marked reduction of varicella incidence and varicella-
related hospitalization in children younger than 6 years
of age in Taiwan. The impact of mass varicella immuni-
zation has so far made it possible for most preschool chil-
dren to be free of varicella and varicella-related
hospitalization in Taiwan. However, children beyond 7
years of age had similar annual incidence before and after
the mass immunization.
As Figure 3 shows the age distribution before the mass
immunization in 2000, the peak age of varicella was 3 to 6
years, which was also the age group of kindergarteners.
Kindergarteners might have more exposure to varicella
and also their hand hygiene and sanitation levels are gen-
erally not as high as adults’ or older school children’s, who
may in turn lead to more varicella cases in kindergarteners
without mass immunization (Figure 3). However, after the
mass immunization, we observed more varicella cases in
the school children than those in 3 to 4-year-old kinder-
garteners (Figure 4), who were supposed to have received
the free varicella vaccine at 1 year of age. Therefore, mass
immunization has changed the age distribution of varicella
cases significantly and the peak age has subsequently
moved to older children without previous immunization.
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Figure 5 Age-specific annual incidence of varicella before (2000-2003) and after the nationwide immunization (2004, 2005, 2006, 2007
and 2008).
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Page 5 of 7Similar results were also reported by Lian et al who found
that the greatest decrease in varicella incidence occurred
in children aged below 6 and the incidence of varicella
shifted to older age groups after implementation of the
one-dose varicella vaccination policy [11]. Lian et al also
found that the incidence in early launch areas was signifi-
cantly lower than that in the other areas in Taiwan [11].
Our study additionally reported the seasonality, varicella-
related hospitalization and complications from 2000 to
2008 in Taiwan. Moreover, our data in this study is
nationwide rather than the selected sample size like that of
Lian et al’ss t u d y .
We found that the annual incidence of children beyond
7 years of age was similar before and after mass immuni-
zation. It’s because most of the school children were not
allowed to receive the free varicella vaccine. Thus, the
varicella incidence of the school children did not change
significantly after the mass immunization in this study.
We suppose that the annual incidence of school children
may decrease several years later if the immunized chil-
dren grow up to be 6 to 12 years old. However, we have
to follow up on the impact of mass immunization on
school children to prove the above assumption several
years later.
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Figure 6 Age-specific annual incidence of varicella-related hospitalization before (2000-2003) and after the nationwide immunization
(2004, 2005, 2006, 2007 and 2008).
Table 1 Demography and complications of 12 fatal varicella cases
Year Age Sex Underlying disease Complications
2000 1 F Nil Encephalitis, septic shock
2000 1 M Unspecified Enzymopathy Pseudomonas septicemia
2000 4 F Acute lymphoblastic leukemia Septicemia
2001 5 F Nil Encephalitis, septicemia
2001 6 F Nil Sudden death
2002 3 F Nil Respiratory failure
2002 3 M Acute lymphoblastic leukemia Not mentioned
2003 2 F Nil Skin/soft tissue infections, streptococcal septicemia
2004 16 M Nil Skin/soft tissue infections, pneumonia, septicemia
2005 1 F Nil Reye’s syndrome
2006 1 M Severe combined immunodeficiency Acute and subacute hepatic necrosis, gastrointestinal hemorrhage
2007 0 M Pulmonary vascular anomaly Hemoptysis, acute respiratory failure
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Page 6 of 7The infants had the highest annual incidence of vari-
cella-related hospitalization both before and after the
mass immunization (Figure 6). Infants cannot receive
the varicella vaccine and they have a higher chance of
severe varicella and more complications [12], so their
varicella-related hospitalization was significantly higher
than the other children.
There were 12 cases of fatality, of which 5 of them
had underlying diseases. Children with underlying dis-
eases such as acute leukemia are more susceptible to
getting severe varicella with complications and have a
significantly higher mortality rate [12]. Therefore, the
varicella vaccine may be administered to children with
acute lymphoblastic leukemia who are in remission, or,
high-titer anti-varicella-zoster virus immune globulin as
post-exposure prophylaxis is recommended for immu-
nocompromised children and newborns that are
exposed maternally to varicella [12].
Currently, the varicella vaccine program consists of a
single-dose vaccination in Taiwan, as it is in Canada,
Korea and Australia [13]. However, both varicella out-
breaks and breakthrough infections have occurred after
the single-dose varicella vaccine program was initiated
[14]. These might be related to a loss of immunity or to
primary vaccine failure. Although the reports are limited,
varicella vaccine effectiveness may be higher when two
doses are administered than when a single-dose is admi-
nistered. In 2006, the United States changed its immuniza-
tion policy by stipulating that 2 doses be administered,
once at 1 year of age and another administered between
the ages of 3 and 4 years old [15]. In Taiwan, boosters in
4-6 year-old children to reduce the breakthrough infection
or amend the primary vaccine failure may be considered if
further epidemiology reveals frequent outbreaks or break-
through infections in kindergarteners.
The major limitation of this study is that we could not
verify the diagnoses because we could just analyze the
NHI database rather than detailed medical charts. How-
ever, at the very least the nationwide database can let us
outline the comprehensive picture of varicella epide-
miology in Taiwan and sketch the impact of nationwide
immunization.
Conclusions
In conclusion, nationwide varicella immunization signifi-
cantly decreased the varicella annual incidence and vari-
cella-related hospitalization in preschool children in
Taiwan. The impact of the varicella vaccine on school-
children may be followed up on several years later.
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